Multilocus sequence typing and nrdA sequence analysis identified 6 different species or genogroups and 13 sequence types (STs) among 15 Achromobacter isolates from cystic fibrosis (CF) patients and 7 species or genogroups and 11 STs among 11 isolates from non-CF patients. Achromobacter xylosoxidans was the most frequently isolated species among CF patients.
Over the study period, 5.6% (14/250) of CF patients were colonized with Achromobacter spp., 9 (3.6%) with chronic colonization and 5 (2.0%) with sporadic colonization, compared with 1.1% to 29.3% in other studies (8) (9) (10) (11) (12) (13) (14) (15) . Clinical characteristics of chronically and sporadically colonized patients are shown in Table 1 . Although other reports have shown A. xylosoxidans colonization to be associated with older age, more pronounced lung damage, and lower lung function values (9, 16) , we were unable to establish a relationship between chronic Achromobacter colonization and lung function, probably because of the small sample size and limited duration of follow-up (1 year). Another study that evaluated patients 3 years after the first isolate suggested that A. xylosoxidans infection might lead to a decline in lung function in a subgroup of chronically infected CF patients (17) .
Molecular characterization based on MLST and nrdA 765 sequencing identified 6 different species or genogroups and 13 different sequence types (STs) among 15 Achromobacter isolates from 14 patients: 10 (71.4%) A. xylosoxidans (ST3, ST20, ST27, ST153, ST154, ST156, ST158, ST160), and one (7.1%) each of Achromobacter genogroup 2a (ST144), Achromobacter genogroup 2b (ST150), Achromobacter genogroup 7 (ST152), Achromobacter genogroup 14 (ST162), and Achromobacter genogroup 17 (ST149) ( Table 2) (18) . Similar diversity of species was also observed in a recent study that included 341 isolates from 86 CF centers in the United States. This study identified 14 different species or genogroups, the most prevalent being A. xylosoxidans (42%), Achromobacter ruhlandii (23.5%), and Achromobacter genogroup 14 (17%) (3). In our study, A. xylosoxidans was more frequently isolated from patients with chronic than sporadic colonization (88.9% versus 20%; P ϭ 0.023).
Because of the genetic diversity of Achromobacter spp. identified, we investigated whether this was also evident among isolates from non-CF patients. Eleven Achromobacter isolates from 11 patients were available for analysis, among which we found 7 differ-ent species or genogroups and 11 different sequence types (STs): 5 (45.4%) A. xylosoxidans (ST16, ST19, ST27, ST157, ST159) and 1 (9.1%) each of Achromobacter genogroup 2a (ST161), Achromobacter genogroup 7 (ST152), Achromobacter spiritinus (genogroup 10; ST151), Achromobacter pulmonis (genogroup 11; ST155), Achromobacter genogroup 12 (ST71), and Achromobacter insolitus (ST93) ( Table 2) .
PFGE analysis showed good correlation between the results of MLST analysis and nrdA 765 sequencing. Each ST corresponded to a different PFGE pattern (Table 2 ). ST27 was identified in two CF patients and one non-CF patient, while ST152 was identified in one CF patient and one non-CF patient. In all cases in which a common ST was found, the PFGE patterns were also indistinguishable, although no epidemiologic link was established between the patients. It is possible that the common strains identified among CF patients could be the result of person-to-person spread, as has been reported elsewhere (13, 14, 17, 19) .
In order to evaluate whether chronic colonization involves the same or different strains over time, we used PFGE to analyze 40 isolates from 9 chronically colonized patients with infections spanning 1 to 9 years. Eight patients harbored the same strain over time. One who was initially colonized with Achromobacter genogroup 17 (PFGE pattern B) was found to carry a different strain of Achromobacter genogroup 7 (PFGE pattern I) 5 years after the initial isolate. Although both long-term colonization with a single strain and acquisition of different strains over time have been described (14, 20) , our results suggest that chronic colonization is more often due to persistence than reinfection (1).
The intrinsic ␤-lactamase bla OXA-114 -like gene is reported to provide a means to identify A. xylosoxidans (7, 21) . Nevertheless, all of our isolates of A. xylosoxidans and the recently described Achromobacter species or genogroups 2a, 12, 14, and 17 were also shown to carry this gene ( Table 2) . Sequencing of the PCR products from 3 representative A. xylosoxidans and 5 non-A. xylosoxidans isolates confirmed our results, suggesting that detection of the ␤-lactamase bla OXA-114 -like gene is not specific for A. xylosoxidans.
In summary, we demonstrated colonization and/or infection in both CF and non-CF patients by a wide diversity of Achromobacter species. We found A. xylosoxidans to be the most common species involved in chronic colonization of CF patients, although further studies are necessary to understand the epidemiology, virulence, and clinical impact of other Achromobacter species. 
